France Prepares to Introduce COVID-19 Health Pass; Places New Restrictions on Arrivals From UK cnsnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnsnews.com Daily Mail and Mail on Sunday newspapers.
transformative and positively impacting their families and caregivers.”
Samantha has a strong track record in patient advocacy and gene therapy development, with deep experience in the development of natural history studies, registries, novel patient centered outcomes, and early access planning as well as access to collaborative networks. She previously served as Chief Patient Access Officer at Lysogene, and prior to that, was Director of External Affairs and Rare Disease Partnerships at Orphan Europe. Samantha was a founding member of several pilot European Reference Networks - virtual networks of healthcare providers aiming to facilitate discussion on complex or rare diseases. Samantha is also active in several scientific and healthcare-related organizations including the International Rare Disease Research Consortium (IRDiRC). She earned an MBA in Life Sciences from Open University’s School of Business, an International Management Degree from ESSEC Business School, and a B
Partnering with the Wuhan Institute of Virology - Rats and a Sinking Ship oyetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oyetimes.com Daily Mail and Mail on Sunday newspapers.
New research has found early promise in a vaccination against chronic allergic asthma. It’s only been carried out in mice so far, so it’s still very early days, but it could potentially pave the way for a long-term approach to treat severe asthma. Off the back of these promising results, the researchers told IFLScience that they’re already in discussions with several hospitals in the hopes of carrying out human trials in the next couple of years.
To wind back a little, asthma causes wheezing, shortness of breath, and a tight feeling around the chest for around 262 million people worldwide. It’s caused by the inflammation in the lungs’ airways, causing them to narrow. While asthma can have a number of different triggers, the root cause of this inflammation is often an overreaction from the immune system against an allergen. Addressing this inflammation is key to treating the condition, but it can prove difficult in some people with severe asthma.
Date Time
EMBL and Inserm to join forces
A memorandum of understanding has been signed between EMBL and Inserm, the French National Institute of Health and Medical Research A memorandum of understanding has been signed between Inserm and EMBL.
EMBL and Inserm, the French National Institute of Health and Medical Research, have signed a memorandum of understanding (MoU) to strengthen their scientific cooperation through joint scientific meetings and conferences, training courses, attracting young talent, and applications for international collaborative funding.
This agreement has been born out of the numerous scientific links already in place between the institutes.
As areas of mutual interest, the MoU identifies numerous scientific themes in the next EMBL Programme, Molecules to Ecosystems. Within the framework of the collaboration, both institutes will focus on these themes, which include microbial ecosystems, infection biology, genomic medicine, exposome research, data scien